Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 8/20 | 0.52 |
| ▸ | SIRT1 | Q96EB6 | 6/20 | 0.52 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11925972 | 1.00 | SIRT2 (0.52) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL11907039 | 0.96 | SIRT2 (0.53) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL11925819 | 0.96 | SIRT2 (0.53) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL4905245 | 0.90 | SIRT2 (0.51) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL4896764 | 0.89 | SIRT2 (0.54) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL16846627 | 0.89 | SIRT2 (0.49) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL11907491 | 0.83 | SIRT2 (0.49) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL31235832 | 0.81 | FOLH1 (0.49) | SIRT2SIRT1MEN1ALDH1A1HPGD | |
| SCHEMBL11925975 | 0.81 | GLP1R (0.53) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL25932961 | 0.81 | SIRT2 (0.59) | SIRT2SIRT1SIRT3FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10689330-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2020-06-23 | — | — | US | disclosed |
| US-10689330-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2020-06-23 | — | — | US | disclosed |
| US-20200165192-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2020-05-28 | — | — | US | disclosed |
| US-10550072-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2020-02-04 | — | — | US | disclosed |
| US-10550072-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2020-02-04 | — | — | US | disclosed |
| US-20180194717-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2018-07-12 | — | — | US | disclosed |
| US-9868696-B2 | Amino acid derivatives and absorbable polymers therefrom | Bezwada Biomedial, LLC (US) | 2018-01-16 | — | — | US | disclosed |
| US-20160257643-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2016-09-08 | — | — | US | disclosed |
| US-20150174290-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2015-06-25 | — | — | US | disclosed |
| US-9012677-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2015-04-21 | — | — | US | disclosed |
| US-20150065586-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2015-03-05 | — | — | US | disclosed |
| US-8901341-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-20130245133-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-8461372-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC | 2013-06-11 | — | — | US | disclosed |
| US-20120208896-A1 | AMINO ACID DERIVATIVES AND ABSORABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC. (US) | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208896-A1 | AMINO ACID DERIVATIVES AND ABSORABLE POLYMERS THEREFROM | SLC7A1, SLC3A2, BCAT2 | SIRT2 4317/4885SIRT1 4492/4885SIRT3 4320/4885 |
| US-20150065586-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | SIRT2 4480/4885SIRT1 4644/4885SIRT3 4525/4885 |
| US-20130245133-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | SIRT2 4480/4885SIRT1 4644/4885SIRT3 4525/4885 |
| US-20160257643-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | SIRT2 4480/4885SIRT1 4644/4885SIRT3 4525/4885 |
| US-10550072-B2 | Amino acid derivatives and absorbable polymers therefrom | SRRM2, SLC7A1, BCAT2 | SIRT2 4480/4885SIRT1 4644/4885SIRT3 4525/4885 |
| US-10689330-B2 | Amino acid derivatives and absorbable polymers therefrom | SRRM2, SLC7A1, BCAT2 | SIRT2 4480/4885SIRT1 4644/4885SIRT3 4525/4885 |
| US-20150174290-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | SIRT2 4480/4885SIRT1 4644/4885SIRT3 4525/4885 |
| US-20180194717-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | SIRT2 4480/4885SIRT1 4644/4885SIRT3 4525/4885 |
| US-20200165192-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | SIRT2 4480/4885SIRT1 4644/4885SIRT3 4525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.